As GBA mutations lead to loss of enzymatic function and autophago–lysosomal defects, it is speculated that AS cannot be sequestered for degradation effectively, building up in PD patient brains and this build up may further inhibit GCase activity [145,158]. Here, GBA1 is linked to Parkinson disease.